StemoniX

StemoniX® is a biotechnology company headquartered in Minnesota, USA, founded in 2014. The company develops drugs by testing human micro-organs such as neural circuits (microBrain®) and cardiac cells (microHeart®). Our mission is to accelerate the discovery of new drugs related to physiology using structured human cells to improve cell-based assay outcomes. We develop and mass-produce human-induced pluripotent stem cell (iPS) heart and neural platforms for drug discovery and development. We also collaborate with drug research and development institutions, utilizing our in-house screening capabilities to test their compounds, create new cell-based models, and conduct large-scale high-throughput screening of their human iPS cells.